Cite
HARVARD Citation
Yang, Z. et al. (2018). Inhibition of stromal‐interacting molecule 1‐mediated store‐operated Ca2+ entry as a novel strategy for the treatment of acquired imatinib‐resistant gastrointestinal stromal tumors. Cancer science. 109 (9), pp. 2792-2800. [Online].